Stephen Gordon - 20 Feb 2023 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role: Chief Financial Officer
Signature: By: /s/ Stephen Gordon
Issuer symbol: TMDX
Transactions as of: 20 Feb 2023
Net transactions value: $0
Form type: 4
Filing time: 22 Feb 2023, 19:00:19 UTC
Previous filing: 03 Feb 2023
Next filing: 02 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMDX	Common Stock	Award	$0	+13,075	+229%	$0.000000	18,789	20 Feb 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TMDX	Stock Option (Right to Buy)	Award	$0	+20,022		$0.000000	20,022	20 Feb 2023	Common Stock	20,022	$66.10	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2	The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 20, 2023 until the option is fully vested on February 20, 2027, subject to continued service.